Navigation Links
Study raises questions about prostate cancer therapies targeting IGF-1
Date:4/30/2008

SEATTLE Therapies under development to treat prostate cancer by inhibiting the ability of insulin-like growth factor (IGF-1) to activate its target receptor could have unexpected results especially if a major tumor suppressor gene p53 is already compromised, according to new research by investigators at Fred Hutchinson Cancer Research Center.

IGF-1 is a polypeptide hormone that can influence growth, differentiation and survival of cells expressing the type 1 receptor (IGF-1R). Past clinical, epidemiological and experimental studies have strongly implicated IGF-1 as a contributing factor in the natural history of prostate cancer. However, very little has been done to prove absolutely that the expression or activation of the IGF-1 signaling pathway at physiologically relevant levels is sufficient to cause a healthy prostate cell to become a cancer cell.

Norman Greenberg, Ph.D., and colleagues conducted a pair of experiments by manipulating gene expression directly in the epithelial compartment of the mouse prostate gland to better understand the role of IGF-1R. In contrast to studies that correlated elevated levels of IGF-1 with the risk of developing prostate cancer, Greenbergs research showed that eliminating IGF-1R expression in an otherwise normal mouse prostate caused the cells to proliferate and become hyperplastic. Although persistent loss of IGF-1R expression ultimately induced cell stasis and death, both of these processes are regulated by the tumor suppressor gene p53 that is commonly mutated in human prostate cancers. Hence the researchers hypothesized that tumors with compromised p53 might not respond predictably to therapies targeting IGF1 signaling.

To test their reasoning they conducted a second experiment by crossing mice carrying the prostate-specific IGF-1R knockout alleles with transgenic mice that develop spontaneous prostate cancer when p53 and select other genes are compromised. The results were as predicted: Pro
'/>"/>

Contact: Dean Forbes
dforbes@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Children More Vulnerable to Harmful Effects of Lead at Age 6 Than as Toddlers, Says New Study
2. Flip Flops, Mulch and No Coat: Study Identifies Surprising Barriers to Outdoor Activity for Kids in Child-Care Centers
3. Penn study finds elderly heart patients with ICD devices live longer after heart failure
4. Physical activity, healthy eating and BMI not linked in older teens: study
5. Salk study links diabetes and Alzheimers disease
6. U of M study: Online intervention paramount for reducing HIV in high-risk population
7. Study Reveals Women Feeling Growing Financial Pressures on Family Life
8. Experimental Blood Substitutes Unsafe, Study Finds
9. Spinal cord injury research hampered by animal models, says new study
10. Study: Casual Video Games Demonstrate Ability to Relieve Stress, Improve Mood: Potential Clinical Significance Highlighted
11. Kaiser Permanente study finds diabetes doubling before motherhood

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...wswire/ -- Reportlinker.com announces that a new m...e: ,, Renal Disease Treatments: Products and T...824/Renal-Disease-Treatments-Products-and-Therapie...ducts and services, providing data for 2008 and es...nd compound annual growth rates (CAGRs) from 2009 ...
(Date:12/2/2009).... 2 The City of Seoul, ...MacroEye and Qualcomm Incorporated (Nasdaq: QCOM ...y announced the expansion of a project that provid...gh the "Seoul Family Helper" program. This projec...rs and senior citizens in order to provide healthc...
(Date:12/2/2009)...could counter recent increases in longevity , ...overall health of the U.S. population has improved...le have quit smoking in droves, but a new study su...rising obesity rates among Americans don,t level o... and obesity continue unchanged, the average life ...
(Date:12/2/2009)...ewswire-USNewswire/ -- Huntington Memorial Hospita...pproval from the Joint Commission, designating the...tington will join the network of "approved stroke ... ,, "This is a significant milestone for the ho...r Pasadena and its surrounding communities," said ...
(Date:12/2/2009).../ - As part of its continued commitment to hemophi...izer, has pledged more than 40 million internation... Federation of Hemophilia (WFH). This is the large...d Program, and will make a significant impact to a...directly support building sustainable national car...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 2Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 3Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 4Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 5Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 6Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 7Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 8Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 9Health News:Reportlinker Adds Renal Disease Treatments: Products and Therapies 10Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 2Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 3Health News:Qualcomm, City of Seoul, Korea Telecom and MacroEye Leverage the Power of 3G to Connect Low Income and Disabled Senior Citizens to Caregivers 4Health News:Health Gains From Lowered Smoking Rates in Jeopardy 2Health News:Health Gains From Lowered Smoking Rates in Jeopardy 3Health News:Huntington Hospital Earns Designation as Primary Stroke Center 2Health News:The WFH receives the largest humanitarian aid donation in its history - Donation represents more than 40 million international units to the WFH 2
...portant at reducing a woman’s risk for heart disea...arch has not been clear on the risks of coronary h...esity studies have failed to look at fitness level...isk. The study included 936 women from four aca...
...reast cancer detected by a mammogram are less like...f the body.// Researchers studied more than 2,5... years ago. Results of the study show women whose... were not detected with mammograms had a 90-percen...
... extremely low body fat whether due to strenuous e...enefit from treatment with the appetite-and-weight...ates leptin may be useful in treating some instanc...blishing how much energy is available to the body ...
... they found that chest pain relief and improved qu...ated // with angioplasty and those on medication ,...hese benefits earlier. Patients treated with s...ced more non-fatal events, such as being hospitali...
...plements containing the omega-3 fatty acid known a...ease // even if you carry a gene that makes you su...ers first bred mice to carry the gene known to cau...ed minimal memory or other brain-related problems....
... and easier way to protect the general population ...oterror attack. Scientists have developed a powder...nhaled through the nose, thus eliminating needle i...owdered formula is more stable than the injected l...
Other Medicine News:
(Date:12/2/2009)... , TAMPA, Fla., Dec. 2 Laser ...vasive spinal surgery, is pleased to announce a p...after an extensive six-month negotiation and clini...argest healthcare provider of minimally invasive s...are. Effective immediately, patients with United H...
(Date:12/2/2009)... , WESTON, Fla., Dec. 2 /PRNewswire-Firs...ink Sheets: ASFX) (the Company), announces that th...roved home needle destruction device (NDD), is in ...lly designed to fill the current demand for home i...sulting from the recent passing of the SB 486 wh...
(Date:12/2/2009)... , LUND, Sweden, December 2 /PR...Development dermatology and wound healing company ...received promising results from a,clinical Phase I...microbial,peptide (AMP) treatment for atopic derma... skin disease where dry skin and the skin,s weaken...
Breaking Medicine Technology:Laser Spine Institute Partners with United Healthcare 2Laser Spine Institute Partners with United Healthcare 3World's Only FDA Approved Home Needle Destruction Device is in Production 2World's Only FDA Approved Home Needle Destruction Device is in Production 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 2Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 3Dermagen Reports Successful Phase I/IIa Clinical Trial for Atopic Dermatitis 4The Quigley Corporation to Host Conference Call to Review Third Quarter Results and Provide Company Update 61125 1The Quigley Corporation to Host Conference Call to Review Third Quarter Results and Provide Company Update 61125 2MAP Pharmaceuticals to Present at the Lazard Capital Markets 6th Annual Healthcare Conference 6155 1GenomeQuest Places ChIP Seq Workflow Solution On SDM 26amp 3B 238220 3BCloud 26amp 3B 238221 3B 14792 1GenomeQuest Places ChIP Seq Workflow Solution On SDM 26amp 3B 238220 3BCloud 26amp 3B 238221 3B 14792 2GenomeQuest Places ChIP Seq Workflow Solution On SDM 26amp 3B 238220 3BCloud 26amp 3B 238221 3B 14792 3GenomeQuest Places ChIP Seq Workflow Solution On SDM 26amp 3B 238220 3BCloud 26amp 3B 238221 3B 14792 4
...cs present preliminary Phase II data for the...d mechanically-ventilated patie...,together with Nektar Therapeutics (Nasdaq: NKTR ...ata on their unique drug-device combination Amikac...nnual meeting. Amikacin,Inhale, currently being st...
... Inc., a fully,integrated critical care biotherape...ed dosing of its Phase 1a trial for its drug candi...e study was a Phase 1, randomized, single blind, p...udy of a single bolus injection of IK-1001,in heal...pharmacokinetics.,The study comprised five dosing ...
Other Medicine Technology:Amikacin Inhale Shows Promising Results in Phase II Study 2Amikacin Inhale Shows Promising Results in Phase II Study 3Amikacin Inhale Shows Promising Results in Phase II Study 4Amikacin Inhale Shows Promising Results in Phase II Study 5Amikacin Inhale Shows Promising Results in Phase II Study 6Amikacin Inhale Shows Promising Results in Phase II Study 7Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection 2Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection 3
Penfield Dissector #1
Leroy Scalp Clips
Raney Scalp Clip System
Disposable Scalp Clip Applier
Medicine Products: